Moscow: Russia is developing two vaccines to help cure the coronavirus, with clinical studies on more than 1,600 people planned before it enters large scale production.
The vaccines are being developed by the Gamaleya National Research Centre for Epidemiology and Microbiology and by the Vektor State Research Center of Virology and Biotechnology of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing.
According to Russian news agency TASS, Deputy Prime Minister Tatyana Golikova said in a meeting with Russian President Vladimir Putin, “Two vaccines have the greatest outlook now. One of them is developed by the Gamaleya National Research Centre for Epidemiology and Microbiology of the Russian Healthcare Ministry jointly with the Russian Defence Ministry’s 48th Central Research Institute.
This means that after the registration one more clinical study of the vaccine will be conducted on 1,600 people. The launch of industrial production of the Gamaleya Centre’s vaccine is planned for September of 2020.